United States · FDA National Drug Code directory
Phenazopyridine HCL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72189-530_1cd4c05a-085d-bae9-e063-6394a90a61ec
- Product NDC
- 72189-530
- Form
- TABLET
- Composition / generic term
- Phenazopyridine HCL
- Labeler
- Direct Rx
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20240105
- Source listing expiry
- 20261231
Source-listed ingredients
- PHENAZOPYRIDINE HYDROCHLORIDE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 TABLET in 1 BOTTLE (72189-530-06) · 72189-530-06
- 9 TABLET in 1 BOTTLE (72189-530-09) · 72189-530-09
- 10 TABLET in 1 BOTTLE (72189-530-10) · 72189-530-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →